Sangamo Therapeutics, Inc. (SGMO)

0.4036 +0.02 (+6.13%) USD  |  NASDAQ  |  Jan 22, 11:26
More

Sangamo Therapeutics EBIT (Quarterly)

EBIT (Quarterly) Chart

View EBIT (Quarterly) for SGMO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBIT (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBIT Definition

View EBIT Definition
Start Trial

EBIT is an acronym for earnings before interest and taxes.

Read full definition.

EBIT (Quarterly) Range, Past 5 Years

View EBIT (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBIT (Quarterly) Benchmarks

View EBIT (Quarterly) Benchmarks
Start Trial
Arcturus Therapeutics Holdings, Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade
Perspective Therapeutics, Inc. Upgrade
Protalix Biotherapeutics, Inc. Upgrade
Armata Pharmaceuticals, Inc. Upgrade